National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
EZN-2285

 A drug used to treat acute lymphoblastic leukemia (ALL). It is a form of the anticancer drug PEG-asparaginase that stays in the body longer. EZN-2285 is an enzyme that breaks down the amino acid asparagine and may block the growth of tumor cells that need asparagine to grow. It is a type of protein synthesis inhibitor. Also called Oncaspar-IV and SC-PEG E. coli L-asparaginase.

Previous Definitions:extraocular, extraosseous, extrapleural pneumonectomy, extravasation, eye cancer
Next Definitions:F-18 16 alpha-fluoroestradiol, F-18 FES, falimarev, fallopian tube, false-negative test result